{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:06:33Z","timestamp":1792181193134,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cmi.2025.07.022","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:50:28Z","timestamp":1753833028000},"page":"1985-1992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nonantimicrobial therapies for recurrent urinary tract infection in women: is there a place for faecal microbiota transfer?"],"prefix":"10.1016","volume":"31","author":[{"given":"Nadim","family":"Cassir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohma","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiscar","family":"Graells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed J.","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Mullish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Benech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.07.022_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: Disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib2","article-title":"Disease burden and long-term trends of urinary tract infections: A worldwide report","volume":"10","author":"Yang","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.cmi.2025.07.022_bib3","first-page":"321","article-title":"American urogynecologic society best-practice statement: recurrent urinary tract infection in adult women","volume":"24","author":"Brubaker","year":"2018","journal-title":"Urogynecology"},{"key":"10.1016\/j.cmi.2025.07.022_bib4","article-title":"Epidemiology and microbiology of recurrent UTI in women in the community in Oxfordshire, UK","volume":"6","author":"Vazquez-Montes","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.07.022_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2010.11.2217","article-title":"Management of complicated urinary tract infections in the era of antimicrobial resistance","volume":"122","author":"Bader","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.cmi.2025.07.022_bib6","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1016\/S1473-3099(23)00778-8","article-title":"A reference standard for urinary tract infection research: A multidisciplinary Delphi consensus study","volume":"24","author":"Bilsen","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib7","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1111\/j.1464-410X.2012.11337.x","article-title":"Systematic review of the impact of urinary tract infections on health-related quality of life","volume":"110","author":"Bermingham","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.cmi.2025.07.022_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40121-014-0054-6","article-title":"Recurrent lower urinary tract infections have a detrimental effect on patient quality of life: A prospective, observational study","volume":"4","author":"Renard","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2025.07.022_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","article-title":"Social and economic burden of recurrent urinary tract infections and quality of life: A patient web-based study (GESPRIT)","volume":"18","author":"Wagenlehner","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcome Res"},{"key":"10.1016\/j.cmi.2025.07.022_bib10","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","article-title":"Epidemiology of urological infections: A global burden","volume":"38","author":"\u00d6zt\u00fcrk","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.cmi.2025.07.022_bib11","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/ndt\/gfx237","article-title":"Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation","volume":"32","author":"Britt","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2025.07.022_bib12","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0b013e3182180535","article-title":"Impact of gram-negative bloodstream infection on long-term allograft survival after kidney transplantation","volume":"91","author":"Al-Hasan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2025.07.022_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41585-018-0106-x","article-title":"Nonantibiotic prevention and management of recurrent urinary tract infection","volume":"15","author":"Sihra","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.cmi.2025.07.022_bib14","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","article-title":"Global antibiotic consumption and usage in humans, 2000\u201318: A spatial modelling study","volume":"5","author":"Browne","year":"2021","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.cmi.2025.07.022_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.022_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jhm.2157","article-title":"Impact of extended-spectrum \u03b2-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection","volume":"9","author":"Macvane","year":"2014","journal-title":"J Hospit Med"},{"key":"10.1016\/j.cmi.2025.07.022_bib17","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1128\/AAC.00431-09","article-title":"Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: A hospital population-based study","volume":"53","author":"Tacconelli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.022_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humic.2018.05.002","article-title":"Intestinal microbiota and antibiotic resistance: perspectives and solutions","volume":"9","author":"Casals-Pascual","year":"2018","journal-title":"Hum Microbio J"},{"key":"10.1016\/j.cmi.2025.07.022_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib21","series-title":"Review on antimicrobial resistance: Tackling drug-resistant infections globally: Final report and recommendations","first-page":"80","author":"O\u2019Neill","year":"2016"},{"key":"10.1016\/j.cmi.2025.07.022_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0025-7125(16)31453-5","article-title":"Urinary tract antiseptics","volume":"66","author":"Mayrer","year":"1982","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cmi.2025.07.022_bib23","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.cmi.2022.06.017","article-title":"Reducing antibiotic use in uncomplicated urinary tract infections in adult women: A systematic review and individual participant data meta-analysis","volume":"28","author":"Kau\u00dfner","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.022_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065217","article-title":"Methenamine hippurate to prevent recurrent urinary tract infections in older women: Protocol for a randomised, placebo-controlled trial (ImpresU)","volume":"12","author":"Heltveit-Olsen","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2025.07.022_bib25","doi-asserted-by":"crossref","DOI":"10.3399\/BJGP.2020.0833","article-title":"Use of methenamine hippurate to prevent urinary tract infections in community adult women: A systematic review and meta-analysis","volume":"71","author":"Bakhit","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2025.07.022_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bju.14606","article-title":"Vaccines for the prevention of recurrent urinary tract infections: A systematic review","volume":"123","author":"Aziminia","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.cmi.2025.07.022_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euf.2019.11.002","article-title":"Role of vaccines for recurrent urinary tract infections: A systematic review","volume":"6","author":"Prattley","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.cmi.2025.07.022_bib28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/374341","article-title":"Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women","volume":"36","author":"Raz","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00192-020-04397-z","article-title":"Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: A meta-analysis of randomized controlled trials","volume":"32","author":"Chen","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.cmi.2025.07.022_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"d-Mannose for prevention of recurrent urinary tract infection among women: A randomized clinical trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.cmi.2025.07.022_bib31","first-page":"CD013608","article-title":"D-mannose for preventing and treating urinary tract infections","volume":"8","author":"Cooper","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2025.07.022_bib32","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cid\/ciad766","article-title":"Effectiveness of prophylactic oral and\/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial","volume":"78","author":"Gupta","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib33","article-title":"Efficacy of probiotics as prophylaxis for urinary tract infections in premenopausal women: A systematic review and meta-analysis","volume":"13","author":"Abdullatif","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.cmi.2025.07.022_bib34","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cmi.2022.08.010","article-title":"The urobiome in men and women: A clinical review","volume":"29","author":"Roth","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.022_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: Use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Hilt","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2025.07.022_bib36","article-title":"Human bacterial repertoire of the urinary tract: A potential paradigm shift","volume":"57","author":"Aur\u00e9lie","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2025.07.022_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01283-14","article-title":"The female urinary microbiome: A comparison of women with and without urgency urinary incontinence","volume":"5","author":"Pearce","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.cmi.2025.07.022_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.860408","article-title":"The urobiomes of adult women with various lower urinary tract symptoms status differ: A re-analysis","volume":"12","author":"Joyce","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cmi.2025.07.022_bib39","article-title":"Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome","volume":"3","author":"Neugent","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.cmi.2025.07.022_bib40","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1073\/pnas.0602136103","article-title":"Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract","volume":"103","author":"Mysorekar","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2025.07.022_bib41","article-title":"Comparative genomics of antibiotic-resistant uropathogens implicates three routes for recurrence of urinary tract infections","volume":"10","author":"Robert","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.cmi.2025.07.022_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2025.07.022_bib43","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41467-019-13467-w","article-title":"Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection","volume":"10","author":"Magruder","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.07.022_bib44","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-5347(01)65154-1","article-title":"Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli","volume":"157","author":"Yamamoto","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.cmi.2025.07.022_bib45","article-title":"Roles of the vagina and the vaginal microbiota in urinary tract infection: Evidence from clinical correlations and experimental models","volume":"8","author":"Lewis","year":"2020","journal-title":"GMS Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib46","article-title":"Gut resident Escherichia coli profile predicts the eighteen-month probability and antimicrobial susceptibility of urinary tract infections","author":"Tchesnokova","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.cmi.2025.07.022_bib47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41564-022-01107-x","article-title":"Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women","volume":"7","author":"Worby","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cmi.2025.07.022_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1805281","article-title":"Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection","volume":"12","author":"Magruder","year":"2020","journal-title":"Gut Microbe"},{"key":"10.1016\/j.cmi.2025.07.022_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11102574","article-title":"abnormal development of microbiota may be a risk factor for febrile urinary tract infection in infancy","volume":"11","author":"Urakami","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.cmi.2025.07.022_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2025.07.022_bib51","article-title":"Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis","volume":"29","author":"Baunwall","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2025.07.022_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2038856","article-title":"The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases","volume":"14","author":"Ghani","year":"2022","journal-title":"Gut Microbe"},{"key":"10.1016\/j.cmi.2025.07.022_bib53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s40121-020-00365-8","article-title":"rUTI resolution after FMT for clostridioides difficile infection: A case report","volume":"10","author":"Aira","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2025.07.022_bib54","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s40121-023-00797-y","article-title":"Early economic assessment of faecal microbiota transplantation for patients with urinary tract infections caused by multidrug-resistant organisms","volume":"12","author":"Baek","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2025.07.022_bib55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s15010-018-1190-9","article-title":"Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection","volume":"46","author":"Biehl","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2025.07.022_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/mdr.2022.0031","article-title":"A case of successful treatment of recurrent urinary tract infection by extended-spectrum \u03b2-lactamase producing klebsiella pneumoniae using oral lyophilized fecal microbiota transplant","volume":"29","author":"Bier","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2025.07.022_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000502336","article-title":"Faecal microbiota transplantation eradicated extended-spectrum beta-lactamase-producing klebsiella pneumoniae from a renal transplant recipient with recurrent urinary tract infections","author":"Grosen","year":"2019","journal-title":"Case Rep Nephrol Dial"},{"key":"10.1016\/j.cmi.2025.07.022_bib58","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciaa948","article-title":"Disease prevention not decolonization: A model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms","volume":"72","author":"Ghani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz398","article-title":"Successful fecal microbiota transplantation in a patient suffering from irritable bowel syndrome and recurrent urinary tract infections","volume":"6","author":"Hocquart","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib60","first-page":"213","article-title":"Fecal putative uropathogen abundance and antibiotic resistance gene carriage in women with refractory recurrent urinary tract infection treated with fecal microbiota transplantation","volume":"28","author":"Jeney","year":"2022","journal-title":"Urogynecology"},{"key":"10.1016\/j.cmi.2025.07.022_bib61","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhin.2020.01.016","article-title":"Effect of faecal microbiota transplantation on recurrent urinary tract infection in a patient with long-term suprapubic urinary catheter","volume":"105","author":"Ramos-Mart\u00ednez","year":"2020","journal-title":"J Hospit Infect"},{"key":"10.1016\/j.cmi.2025.07.022_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx047","article-title":"Fecal microbiota transfer for multidrug-resistant gram-negatives: A clinical success combined with microbiological failure","volume":"4","author":"Stalenhoef","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00853-20","article-title":"Gram-negative taxa and antimicrobial susceptibility after fecal microbiota transplantation for recurrent clostridioides difficile infection","volume":"5","author":"Steed","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2025.07.022_bib64","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10096-023-04635-4","article-title":"Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection","volume":"42","author":"Tariq","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib65","doi-asserted-by":"crossref","first-page":"ofy016","DOI":"10.1093\/ofid\/ofy016","article-title":"Fecal microbiota transplant for refractory Clostridium difficile infection interrupts 25-year history of recurrent urinary tract infections","volume":"5","author":"Wang","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib66","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/SPV.0000000000001350","article-title":"Fecal microbiota transfer for clostridium difficile infection and its effects on recurrent urinary tract infection","volume":"29","author":"Wood","year":"2023","journal-title":"Urogynecology"},{"key":"10.1016\/j.cmi.2025.07.022_bib67","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.3748\/wjg.v23.i39.7174","article-title":"Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series","volume":"23","author":"Lahtinen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cmi.2025.07.022_bib68","doi-asserted-by":"crossref","first-page":"O977","DOI":"10.1111\/1469-0691.12683","article-title":"Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease","volume":"20","author":"Singh","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.022_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100420","article-title":"Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection","volume":"24","author":"Abdali","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2025.07.022_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000001495","article-title":"Oral fecal microbiota transplant capsules are safe and effective for recurrent clostridioides difficile infection: A systematic review and meta-analysis","volume":"55","author":"Du","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cmi.2025.07.022_bib71","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cmi.2021.11.006","article-title":"How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection","volume":"28","author":"Ghani","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.022_bib72","doi-asserted-by":"crossref","first-page":"ofac324","DOI":"10.1093\/ofid\/ofac324","article-title":"Transmission of antibiotic-susceptible Escherichia coli causing urinary tract infections in a fecal microbiota transplantation recipient: Consequences for donor screening?","volume":"9","author":"Vendrik","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211017725","article-title":"The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection","volume":"14","author":"Mullish","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.cmi.2025.07.022_bib74","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1053\/j.gastro.2018.07.014","article-title":"Inhibiting growth of clostridioides difficile by restoring valerate, produced by the intestinal microbiota","volume":"155","author":"McDonald","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2025.07.022_bib75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/IAI.01197-12","article-title":"Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization","volume":"81","author":"Ubeda","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2025.07.022_bib76","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.aad9382","article-title":"Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens","author":"Pamer","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cmi.2025.07.022_bib77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.it.2012.05.003","article-title":"Antibiotics, microbiota, and immune defense","volume":"33","author":"Ubeda","year":"2012","journal-title":"Trend Immunol"},{"key":"10.1016\/j.cmi.2025.07.022_bib78","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/QCO.0b013e3283630dd3","article-title":"The intestinal microbiota and susceptibility to infection in immunocompromised patients","volume":"26","author":"Taur","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1084\/jem.20180399","article-title":"Enlisting commensal microbes to resist antibiotic-resistant pathogens","volume":"216","author":"Keith","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.cmi.2025.07.022_bib80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12563","article-title":"The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens","volume":"279","author":"Kim","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cmi.2025.07.022_bib81","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M18-3635","article-title":"Incidence of bloodstream infections, length of hospital stay, and survival in patients with recurrent clostridioides difficile infection treated with fecal microbiota transplantation or antibiotics a prospective cohort study","volume":"171","author":"Ianiro","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.07.022_bib82","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1093\/cid\/ciaa737","article-title":"Oral capsulized fecal microbiota transplantation for eradication of carbapenemase-producing enterobacteriaceae colonization with a metagenomic perspective","volume":"73","author":"Bar-Yoseph","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.022_bib83","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Abbas","year":"2024","journal-title":"Clin Microbiol Rev"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25003635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25003635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:26:56Z","timestamp":1772882816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25003635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":83,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1198743X25003635"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.07.022","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonantimicrobial therapies for recurrent urinary tract infection in women: is there a place for faecal microbiota transfer?","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}